Inside Novo Nordisk’s Path to Open Source for the Pharma and Beyond @appsilon_official
Inside Novo Nordisk’s Path to Open Source for the Pharma and Beyond  @appsilon_official
Uploaded April 2025 | Updated September 2026, 2 weeks ago
#datascience #dataanalysis #technology #sastor #clinicaldataanalysis

Ari Siggaard Knoph from Novo Nordisk shares how the company transitioned from SAS to R for FDA submissions. From early Shiny apps to full-scale open-source workflows, learn how this shift accelerated innovation, attracted top talent, and redefined clinical programming.

In this episode, you will learn:
▪︎ How Novo Nordisk transitioned from legacy systems to R for regulatory submissions
▪︎ How Shiny applications became the catalyst for internal buy-in
▪︎ How open-source adoption has broadened the company’s talent pool and improved productivity
▪︎ Future directions in pharma tech

Nat Chrzanowska
linkedin.com/in/nat-chrzanowska
__________________________________________
More about Appsilon: ► appsilon.com
Appsilon empowers pharmaceutical and life sciences companies to leverage open-source technology for faster, data-driven decision-making in regulated environments. Schedule a free consultation with our expert
appsilon.com/contact-us
We design scalable and user-friendly Shiny dashboards to help you make data-driven decisions.
appsilon.com/services/data-dashboards
We design and implement Statistical Computing Environment for R and Python for efficient data analysis:
appsilon.com/services/sce
We design, implement, and optimise data analysis environments so you can focus focus on insights and innovation.
appsilon.com/services/platform
Where Technology Meets Science podcast is available on all podcasting platforms:
► Spotify: open.spotify.com/show/6MckhYFZCwGU4Op6P09foR
► Apple Podcasts: apple.co/3CJDdVy
__________________________________________
For more insights about how technology helps scientists push the boundaries of data analysis and reporting check out our blog:
appsilon.com/blog
LinkedIn: linkedin.com/company/appsilon
_________________________________________

00:00 – Introduction to the episode and our guest
02:24 – Transition to R-based submissions
08:43 – Attracting talent with modern technologies
11:48 – Shifting the mindset from coding to software development
18:15 – Lessons learned in change management
25:10 – Future projects and AI integration
30:20 – The unsolved problem in the field
31:43 – Outro and closing remarks
Inside Novo Nordisk’s Path to Open Source for the Pharma and BeyondCan machine learning help build better #neuroscience clinical trials?Jon Harmon: Baking JavaScript into a Shiny PackageBest practices for coding Shiny apps with Rhino TeamSo, You Want to Become an R Shiny Developer? Shiny Gathering Live from Appsilon RetreatMachine Made Human Motion - using ML to generate animations | Appsilon x Bones StudioShowcasing Life Science Utility with an All In One Platform for Molecular Bacterial TypingShinyConf Roundtable: Empowering diversity in R (Shiny)We dont need to validate everything: our shift from myth based to risk based validationShiny in clinical research: from SAS to Shiny | ShinyConf 2024CSV vs. Parquet - advantages, drawbacks and differencesCancerTrialMatch: a web framework for the management of clinical trials at precision oncology center
Appsilon |

Inside Novo Nordisk’s Path to Open Source for the Pharma and Beyond

SHARE TO X SHARE TO REDDIT SHARE TO FACEBOOK WALLPAPER